Entity Central Index Key Cover [Abstract] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity File Number Entity File Number Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Document Type Document Type Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Entity Current Reporting Status Entity Current Reporting Status Entity Interactive Data Current Entity Interactive Data Current Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period Entity Shell Company Entity Shell Company Entity Incorporation, State or Country Code Entity Incorporation State Country Code Entity Address, Address Line One Entity Address Address Line1 Entity Address, Address Line Two Entity Address Address Line2 Entity Address, Address Line Three Entity Address Address Line3 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Title of 12(b) Security Security12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Document Quarterly Report Document Quarterly Report Document Transition Report Document Transition Report Entity Common Stock, Shares Outstanding Entity Common Stock Shares Outstanding Statement Of Financial Position [Abstract] ASSETS Assets [Abstract] CURRENT ASSETS: Assets Current [Abstract] Cash and cash equivalents Cash And Cash Equivalents At Carrying Value Trade receivables, net Accounts Receivable Net Current Inventory, net Inventory Net Prepaid expenses Prepaid Expense Current Other current assets Other Assets Current Total current assets Assets Current NONCURRENT ASSETS: Assets Noncurrent [Abstract] Property and equipment, net Property Plant And Equipment Net Restricted cash Restricted Cash Noncurrent Intangible assets, net Intangible Assets Net Excluding Goodwill Other noncurrent assets Other Assets Noncurrent Total noncurrent assets Assets Noncurrent TOTAL ASSETS Assets LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities And Stockholders Equity [Abstract] CURRENT LIABILITIES: Liabilities Current [Abstract] Trade payables Accounts Payable Current Accrued compensation Accrued Employee Benefits Current Accrued expenses Accrued Liabilities Current Other current liabilities Other Liabilities Current Total current liabilities Liabilities Current NONCURRENT LIABILITIES: Liabilities Noncurrent [Abstract] Long term debt, net Long Term Debt Noncurrent Other noncurrent liabilities Other Liabilities Noncurrent Total noncurrent liabilities Liabilities Noncurrent TOTAL LIABILITIES Liabilities COMMITMENTS AND CONTINGENCIES (Note 9) Commitments And Contingencies STOCKHOLDERS’ EQUITY: Stockholders Equity [Abstract] Preferred stock - $0.00001 par value; 10,000,000 shares and 0 shares authorized at June 30, 2021 and December 31, 2020, respectively; 0 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively Preferred Stock Value Common stock—$0.00001 par value; 500,000,000 shares authorized at June 30, 2021 and December 31, 2020, respectively; 57,000,139 shares and 56,890,569 issued and outstanding at June 30, 2021 and December 31, 2020, respectively Common Stock Value Additional paid in capital Additional Paid In Capital Common Stock Accumulated deficit Retained Earnings Accumulated Deficit TOTAL STOCKHOLDERS’ EQUITY Stockholders Equity TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities And Stockholders Equity Preferred stock, par value Preferred Stock Par Or Stated Value Per Share Preferred stock, shares authorized Preferred Stock Shares Authorized Preferred stock, shares issued Preferred Stock Shares Issued Preferred stock, shares outstanding Preferred Stock Shares Outstanding Common stock, par value Common Stock Par Or Stated Value Per Share Common stock, shares authorized Common Stock Shares Authorized Common stock, shares issued Common Stock Shares Issued Common stock, shares outstanding Common Stock Shares Outstanding Income Statement [Abstract] Net product revenues Revenue From Contract With Customer Excluding Assessed Tax Cost of product sold Cost Of Goods And Services Sold Gross profit Gross Profit Operating expenses: Operating Expenses [Abstract] Research and development Research And Development Expense Sales and marketing Selling And Marketing Expense General and administrative General And Administrative Expense Total operating expenses Operating Expenses Operating income (loss) Operating Income Loss Loss on debt extinguishment Gains Losses On Extinguishment Of Debt Other income (expense), net Other Nonoperating Income Expense Interest expense, net Interest Income Expense Nonoperating Net Income (loss) before income taxes Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest Income taxes Income Tax Expense Benefit Net income (loss) and comprehensive income (loss) Net Income Loss Accumulation of dividends on preferred stock Preferred Stock Dividends Income Statement Impact Net income (loss) available to common stockholders Net Income Loss Available To Common Stockholders Basic EARNINGS (LOSS) PER SHARE: Earnings Per Share [Abstract] Basic Earnings Per Share Basic Diluted Earnings Per Share Diluted Weighted average number of shares of common stock - basic Weighted Average Number Of Shares Outstanding Basic Weighted average number of shares of common stock - diluted Weighted Average Number Of Diluted Shares Outstanding Dividends and dividends in excess of retained earnings adjustments to additional paid in capital. Accretion of dividends in excess of retained earnings adjustments to additional paid in capital. Temporary equity dividend. Statement Of Stockholders Equity [Abstract] Statement [Table] Statement [Table] Equity Components Statement Equity Components [Axis] Equity Component Equity Component [Domain] Common Stock Common Stock [Member] Additional Paid-in Capital Additional Paid In Capital [Member] Accumulated Deficit Retained Earnings [Member] Class of Stock Statement Class Of Stock [Axis] Class of Stock Class Of Stock [Domain] Series A convertible preferred stock. Series A Convertible Preferred Stock Series A Convertible Preferred Stock [Member] Series B convertible preferred stock. Series B Convertible Preferred Stock Series B Convertible Preferred Stock [Member] Series C convertible preferred stock. Series C Convertible Preferred Stock Series C Convertible Preferred Stock [Member] Statement [Line Items] Statement [Line Items] Beginning balance Convertible Preferred Stock, beginning balance, Shares Temporary Equity Shares Outstanding Convertible Preferred Stock, beginning balance Temporary Equity Carrying Amount Attributable To Parent Beginning balance, shares Shares Outstanding Net income (loss) Preferred stock dividend Dividends And Dividends In Excess Of Retained Earnings Adjustments To Additional Paid In Capital Preferred stock accretion Accretion Of Dividends In Excess Of Retained Earnings Adjustments To Additional Paid In Capital Temporary equity, Preferred stock dividend Temporary Equity Dividend Temporary equity, Preferred stock accretion Temporary Equity Accretion Of Dividends Exercise of stock options Stock Issued During Period Value Stock Options Exercised Exercise of stock options, Shares Stock Issued During Period Shares Stock Options Exercised Stock-based compensation Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Repurchase and cancellation of common units Stock Repurchased And Retired During Period Value Repurchase and cancellation of common shares, Shares Stock Repurchased And Retired During Period Shares Ending balance Convertible Preferred Stock, Ending balance, Shares Convertible Preferred Stock, ending balance Ending balance, shares Stock appreciation rights market adjustment. Payments of extinguishment of debt exit fees. Cash paid during the year for milestones. Preferred stock accrued return. Preferred stock accretion of issuance costs. Warrant financing. Statement Of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Net Cash Provided By Used In Operating Activities [Abstract] Net income (loss) Profit Loss Adjustments to reconcile net loss to net cash used in operating activities: Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Depreciation Depreciation Intangible amortization Amortization Of Intangible Assets Stock-based and employee stock purchase compensation expense Share Based Compensation Stock appreciation rights market adjustment Stock Appreciation Rights Market Adjustment Warrant expense Fair Value Adjustment Of Warrants Debt issuance costs amortization Amortization Of Financing Costs Loss on debt extinguishment Change in operating assets and liabilities: Increase Decrease In Operating Capital [Abstract] Trade receivables Increase Decrease In Accounts Receivable Inventory Increase Decrease In Inventories Prepaid expenses and other assets Increase Decrease In Prepaid Deferred Expense And Other Assets Other non-current assets Increase Decrease In Other Noncurrent Assets Trade payables Increase Decrease In Accounts Payable Trade Accrued expenses and other current liabilities Increase Decrease In Accrued Liabilities And Other Operating Liabilities Other non-current liabilities Increase Decrease In Other Noncurrent Liabilities Net cash provided by (used in) operating activities Net Cash Provided By Used In Operating Activities CASH FLOWS FROM INVESTING ACTIVITIES: Net Cash Provided By Used In Investing Activities [Abstract] Purchase of property and equipment Payments To Acquire Property Plant And Equipment Milestone and acquisition of intangible asset Payments To Acquire Intangible Assets Net cash used in investing activities Net Cash Provided By Used In Investing Activities CASH FLOWS FROM FINANCING ACTIVITIES: Net Cash Provided By Used In Financing Activities [Abstract] Proceeds from long term debt Proceeds From Issuance Of Long Term Debt Debt issuance costs Payments Of Debt Issuance Costs Extinguishment of debt Payments Of Debt Extinguishment Costs Extinguishment of debt exit fees Payments Of Extinguishment Of Debt Exit Fees Proceeds from exercised options Proceeds From Stock Options Exercised Repurchase of common stock Payments For Repurchase Of Common Stock Net cash provided by financing activities Net Cash Provided By Used In Financing Activities NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CASH, CASH EQUIVALENTS, AND RESTRICTED CASH—Beginning of period Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CASH, CASH EQUIVALENTS, AND RESTRICTED CASH—End of period Supplemental Disclosure of Cash Flow Information: Supplemental Cash Flow Information [Abstract] Cash paid during the year for interest Interest Paid Net Cash paid during the year for milestones Cash Paid For Milestones Supplemental Disclosures of Noncash Investing and Financing Activities: Noncash Investing And Financing Items [Abstract] Preferred Stock accrued return Preferred Stock Accrued Return Accretion of issuance costs Preferred Stock Accretion Of Issuance Costs Warrant financing Warrant Financing Organization Consolidation And Presentation Of Financial Statements [Abstract] Organization and Description of Business Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block] Liquidity and capital resources. Liquidity and capital resources. Liquidity And Capital Resources [Abstract] Liquidity and Capital Resources Liquidity And Capital Resources [Text Block] Accounting Policies [Abstract] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Inventory Disclosure [Abstract] Inventory Inventory Disclosure [Text Block] Intangible Assets Net Excluding Goodwill [Abstract] Intangible Assets Intangible Assets Disclosure [Text Block] License agreement. License agreement. License Agreement [Abstract] License Agreement License Agreement [Text Block] Payables And Accruals [Abstract] Accrued Expenses Accounts Payable And Accrued Liabilities Disclosure [Text Block] Debt Disclosure [Abstract] Debt Debt Disclosure [Text Block] Commitments And Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments And Contingencies Disclosure [Text Block] Convertible preferred stock. Stockholders Equity Note [Abstract] Convertible Preferred Stock Convertible Preferred Stock [Text Block] Stockholders' Equity (Deficit) Stockholders Equity Note Disclosure [Text Block] Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] Stock Incentive Plan and Stock-based Compensation Disclosure Of Compensation Related Costs Share Based Payments [Text Block] Warrants disclosure. Warrants And Rights Note Disclosure [Abstract] Warrants Warrants Disclosure [Text Block] Earnings per Share Earnings Per Share [Text Block] Related Party Transactions [Abstract] Related-party Transactions Related Party Transactions Disclosure [Text Block] Subsequent Events [Abstract] Subsequent Events Subsequent Events [Text Block] Basis of Presentation Basis Of Accounting Policy Policy [Text Block] Use of Estimates Use Of Estimates Fair Value of Financial Instruments Fair Value Of Financial Instruments Policy Cash, Cash Equivalents and Restricted Cash Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy Concentrations of Risk Concentration Risk Credit Risk Cost of Product Sold Cost Of Sales Policy [Text Block] Recently Issued Accounting Pronouncements New Accounting Pronouncements Policy Policy [Text Block] Schedule of Reconciliation of Cash, Cash Equivalents, and Restricted Cash Schedule Of Restricted Cash And Cash Equivalents [Text Block] Schedule of Inventory Net Schedule Of Inventory Current Table [Text Block] Schedule of Expected Future Annual Amortization Expense for Unamortized Intangible Assets Scheduleof Finite Lived Intangible Assets Future Amortization Expense Table [Text Block] Schedule of Gross Carrying Amount and Net Book Value of Intangible Assets Schedule Of Finite Lived Intangible Assets Table [Text Block] Schedule of Accrued Expenses Schedule Of Accrued Liabilities Table [Text Block] Balances of OrbiMed Loan Schedule Of Debt Table [Text Block] Interest Expense Related to OrbiMed Loan and CRG Loan Interest Income And Interest Expense Disclosure Table [Text Block] Summary of Lease Payment Obligations Lessee Operating Lease Liability Maturity Table [Text Block] Summary of Changes in Stock Options Granted Schedule Of Share Based Compensation Stock Options Activity Table [Text Block] Summary of Changes in SARs Granted under 2017 Plan Schedule Of Share Based Compensation Stock Appreciation Rights Award Activity Table [Text Block] Summary of Changes in RSUs Granted under 2020 Plan Schedule Of Share Based Compensation Restricted Stock Units Award Activity Table [Text Block] Summary of Assumptions Used to Value Awards Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block] Summary of Stock-based Compensation Expense Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block] Summary of future compensation expense. Summary of Future Compensation Expense Summary Of Future Compensation Expense Table [Text Block] Summary of Computation of Basic and Diluted Net Loss per Share Schedule Of Earnings Per Share Basic And Diluted Table [Text Block] Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block] Organization and description of business. Organization and description of business. Organization And Description Of Business [Table] Organization And Description Of Business [Table] Sale of Stock Subsidiary Sale Of Stock [Axis] Sale of Stock Sale Of Stock Name Of Transaction [Domain] IPO I P O [Member] Over-Allotment Option Over Allotment Option [Member] Organization And Description Of Business [Line Items] Organization And Description Of Business [Line Items] Stock issued during period, shares Stock Issued During Period Shares New Issues Shares issued, price per share Shares Issued Price Per Share Proceeds from issuance of stock Proceeds From Issuance Initial Public Offering Underwriting discounts and commissions and offering expenses Payments Of Stock Issuance Costs Stock issued for conversion of convertible securities Stock Issued During Period Shares Conversion Of Convertible Securities Purchase of common stock upon exercise of warrants Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Reverse stock split ratio, description Stockholders Equity Reverse Stock Split Reverse stock split ratio Stockholders Equity Note Stock Split Conversion Ratio1 Liquidity and capital resources. Liquidity and capital resources. Liquidity And Capital Resources [Table] Liquidity And Capital Resources [Table] Lender Name Line Of Credit Facility [Axis] Line of Credit Facility, Lender Line Of Credit Facility Lender [Domain] OrbiMed Royalty & Credit Opportunities, LP. OrbiMed Royalty & Credit Opportunities, LP. Orbi Med Royalty Credit Opportunities L P [Member] Liquidity And Capital Resources [Line Items] Liquidity And Capital Resources [Line Items] Accumulated deficit Proceeds from issuance of common stock, net Proceeds From Issuance Of Common Stock Aggregate proceeds from loan Proceeds From Lines Of Credit Total cash, cash equivalents, and restricted cash shown in the statements of cash flows Number of major customers. Summary of significant accounting policies. Summary of significant accounting policies. Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Customer Major Customers [Axis] Customer Name Of Major Customer [Domain] Three customers. Three Customers Three Customers [Member] Caremark LLC. Caremark LLC Caremark L L C [Member] PANTHERx Specialty Pharmacy LLC. PANTHERx Specialty Pharmacy LLC P A N T H E Rx Specialty Pharmacy L L C [Member] Accredo Health Group, Inc. Accredo Health Group, Inc Accredo Health Group Inc [Member] Concentration Risk Benchmark Concentration Risk By Benchmark [Axis] Concentration Risk Benchmark Concentration Risk Benchmark [Domain] Accounts Receivable Accounts Receivable [Member] Concentration Risk Type Concentration Risk By Type [Axis] Concentration Risk Type Concentration Risk Type [Domain] Customer Concentration Risk Customer Concentration Risk [Member] Product Revenues Sales Revenue Product Line [Member] Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Number of customers Number Of Major Customers Concentration risk percentage Concentration Risk Percentage1 Amortization of acquired developed technology Raw materials Inventory Raw Materials Work in process Inventory Work In Process Finished goods Inventory Finished Goods Inventory, gross Inventory Gross Reserve for obsolescence Inventory Valuation Reserves Total inventory, net License agreement milestone payments paid. Schedule Of Finite Lived Intangible Assets [Table] Schedule Of Finite Lived Intangible Assets [Table] Product and Service Product Or Service [Axis] Product and Service Products And Services [Domain] WAKIX. Upon FDA Approval of WAKIX W A K I X [Member] Finite Lived Intangible Assets [Line Items] Finite Lived Intangible Assets [Line Items] License agreement milestone payments paid License Agreement Milestone Payments Paid Useful life of intangible asset Finite Lived Intangible Asset Useful Life Remaining useful life Finite Lived Intangible Assets Remaining Amortization Period1 Finite Lived Intangible Assets Net Amortization Expense Rolling Maturity [Abstract] 2021 (excluding the six months ended June 30, 2021) Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year 2022 Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months 2023 Finite Lived Intangible Assets Amortization Expense Rolling Year Two 2024 Finite Lived Intangible Assets Amortization Expense Rolling Year Three 2025 Finite Lived Intangible Assets Amortization Expense Rolling Year Four Total Finite Lived Intangible Assets Net Gross Carrying Amount Intangible Assets Gross Excluding Goodwill Accumulated Amortization Finite Lived Intangible Assets Accumulated Amortization Net Book Value License agreement milestone payments Due. Licensing agreement milestone fees Amount of aggregate net sales attaining. License agreement additional milestone payments due. Accrued milestone payment current. License agreement. License agreement. License Agreement [Table] License Agreement [Table] Counterparty Name Counterparty Name [Axis] Counterparty Name Repurchase Agreement Counterparty Name [Domain] Bioprojet. Bioprojet Bioprojet [Member] Scenario Statement Scenario [Axis] Scenario Scenario Unspecified [Domain] Upon achievement of aggregate net sales. Attaining $500,000 Aggregate Net Sales Upon Achievement Of Aggregate Net Sales [Member] Geographical Statement Geographical [Axis] Geographical Segment Geographical [Domain] United States UNITED STATES Pitolisant’s. Upon Acceptance by FDA of Pitolisant’s Pitolisants [Member] Sales-based, Trademark and Tiered Royalties Product [Member] License Agreement [Line Items] License Agreement [Line Items] License agreement, milestone payment due License Agreement Milestone Payments Due Licensing agreement milestone fees Licensing Agreement Milestone Fees License agreement, additional milestone payment due License Agreement Additional Milestone Payments Due Amount of Aggregate Net Sales Attaining Amount Of Aggregate Net Sales Attaining Accrued Sales Based Trademark and Royalties Accrued Royalties Current Accrued milestone payment Accrued Milestone Payment Current Accrued rebates and other sales deductions. Accrued research and development current Accrued professional fees, consulting, and other services. Royalties due to third parties Rebates and other sales deductions Accrued Rebates And Other Sales Deductions Current Selling and marketing Accrued Marketing Costs Current Research and development Accrued Research And Development Current Professional fees, consulting, and other services Accrued Professional Fees Consulting And Other Services Other expenses Other Accrued Liabilities Current Milestone payment Accrued expenses Debt instrument number of tranches. Debt instrument compound interest rate. Debt Instrument [Table] Debt Instrument [Table] Debt Instrument Debt Instrument [Axis] Debt Instrument, Name Debt Instrument Name [Domain] Multi-draw loan agreement. Multi-draw Loan Agreement Multi Draw Loan Agreement [Member] CRG Servicing LLC. CRG Servicing LLC C R G Servicing L L C [Member] Credit agreement. Credit Agreement Credit Agreement [Member] Financial Instrument Financial Instrument [Axis] Financial Instruments Transfers And Servicing Of Financial Instruments Types Of Financial Instruments [Domain] Warrants Warrant [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Aggregate principal amount Line Of Credit Facility Maximum Borrowing Capacity Maturity date Line Of Credit Facility Expiration Date1 Fixed interest rate Debt Instrument Interest Rate Stated Percentage Number of tranches Debt Instrument Number Of Tranches Percentage of interest payable in cash Debt Instrument Interest Rate During Period Percentage of Compounded interest rate Debt Instrument Compound Interest Rate Long-term Debt, Gross Debt Instrument Carrying Amount Cash proceeds received Proceeds From Issuance Of Debt Amortized issuance costs Deferred Finance Costs Net Term of loan Debt Instrument Term Debt instrument variable interest rate. Extinguishment of debt exit fee. Debt instrument exit fee percentage. Variable interest rate Debt Instrument Variable Interest Rate Basis spread on variable rate Debt Instrument Basis Spread On Variable Rate1 Debt instrument exit fee percentage Debt Instrument Exit Fee Percentage Extinguishment of loan, amount Extinguishment Of Debt Amount Exit fee Extinguishment Of Debt Exit Fees Write-off of the remaining unamortized debt issuance costs Write Off Of Deferred Debt Issuance Cost Fair value of loan Debt Instrument Fair Value Warrants initial exercise price Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Fair value of warrants Unamortized debt issuance costs Deferred Finance Costs Gross Debt instrument exit fees. Unamortized debt discount associated with exit fee, debt financing costs and discount with warrant financing. OrbiMed Liability component - principal Exit fee Debt Instrument Exit Fees Unamortized debt discount associated with the exit fee, debt financing costs and discount with warrant financing Unamortized Debt Discount Associated With Exit Fee Debt Financing Costs And Discount With Warrant Financing Liability component - net carrying value OrbiMed Royalty & Credit Opportunities, LP and CRG Servicing LLC. OrbiMed and CRG Orbi Med Royalty Credit Opportunities L P And C R G Servicing L L C [Member] Interest on principal balance Interest Expense Debt Excluding Amortization Total term loan interest expense Interest Expense Debt Operating lease office space. Operating lease expiration month and year. Loss Contingencies [Table] Loss Contingencies [Table] Northbrook, IL. Northbrook, IL Northbrook I L [Member] Plymouth Meeting, PA. Plymouth Meeting, PA Plymouth Meeting P A [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Operating lease square feet of office space Operating Lease Office Space Operating lease expiration month and year Operating Lease Expiration Month And Year Rent expense Operating Lease Expense 2021 (excluding the six months ended June 30, 2021) Lessee Operating Lease Liability Payments Remainder Of Fiscal Year 2022 Lessee Operating Lease Liability Payments Due Next Twelve Months 2023 Lessee Operating Lease Liability Payments Due Year Two 2024 Lessee Operating Lease Liability Payments Due Year Three 2025 Lessee Operating Lease Liability Payments Due Year Four Thereafter Lessee Operating Lease Liability Payments Due After Year Five Total Lessee Operating Lease Liability Payments Due Schedule Of Stock By Class [Table] Schedule Of Stock By Class [Table] Class Of Stock [Line Items] Class Of Stock [Line Items] Convertible preferred stock, shares authorized Temporary Equity Shares Authorized Convertible preferred stock, shares issued Temporary Equity Shares Issued Convertible preferred stock, shares outstanding Convertible preferred stock, purchase price Temporary Equity Par Or Stated Value Per Share Convertible preferred stock aggregate amount Percentage preferred stock accrued dividends Preferred Stock Dividend Rate Percentage Preferred stock dividend declared Dividends Preferred Stock Preferred stock conversion ratio. Underwriting discounts and commissions and offering expenses. Preferred stock, conversion basis Preferred Stock Conversion Basis Preferred stock conversion ratio Preferred Stock Conversion Ratio Issuance of shares upon initial public offering Net proceeds from initial public offering Underwriting discounts and commissions and offering expenses Underwriting Discounts And Commissions And Offering Expenses Common stock, voting rights Common Stock Voting Rights Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Plan Name Plan Name [Axis] Plan Name Plan Name [Domain] Two thousand seventeen equity incentive plan. 2017 Plan Two Thousand Seventeen Equity Incentive Plan [Member] Incentive award plan two thousand twenty. 2020 Plan Incentive Award Plan Two Thousand Twenty [Member] Two thousand seventeen equity incentive plan and two thousand twenty incentive award plan. 2017 and 2020 Plans Two Thousand Seventeen Equity Incentive Plan And Two Thousand Twenty Incentive Award Plan [Member] Employee Stock Purchase Plan. Employee Stock Purchase Plan Employee Stock Purchase Plan [Member] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Stock options contractual term Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period Number of Awards, Awards outstanding, Beginning balance Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Number of Awards, Awards issued Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Number of Awards, Awards exercised Number of Awards, Awards forfeited Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Number of Awards, Awards outstanding, Ending balance Weighted-Average Exercise Price, Awards outstanding, Beginning balance Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Weighted-Average Exercise Price, Awards issued Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price Weighted-Average Exercise Price, Awards exercised Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price Weighted-Average Exercise Price, Awards forfeited Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price Weighted-Average Exercise Price, Awards outstanding, Ending balance Weighted-Average Remaining Contractual Term, Balance Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 Share based compensation arrangement by share based payment award equity instruments other than options exercised in period. Award Type Award Type [Axis] Award Type Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain] SARs Granted under 2017 Plan Stock Appreciation Rights S A R S [Member] Number of Awards, Awards outstanding, Beginning balance Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Number of Awards, Awards issued Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Number of Awards, Awards exercised Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Number of Awards, Awards forfeited Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Number of Awards, Awards outstanding, Ending balance Share based compensation arrangement by share based payment award equity instruments other than options non-vested weighted-average exercise price. Share based compensation arrangement by share based payment award equity instruments other than options non-vested weighted-average exercise price grants in period. Share based compensation arrangement by share based payment award equity instruments other than options non-vested weighted-average exercise price exercised in period. Share based compensation arrangement by share based payment award equity instruments other than options non-vested weighted-average exercise price forfeited in period. Weighted-Average Exercise Price, Awards outstanding, Beginning balance Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Non Vested Weighted Average Exercise Price Weighted-Average Exercise Price, Awards issued Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Non Vested Weighted Average Exercise Price Grants In Period Weighted-Average Exercise Price, Awards exercised Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Non Vested Weighted Average Exercise Price Exercised In Period Weighted-Average Exercise Price, Awards forfeited Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Non Vested Weighted Average Exercise Price Forfeited In Period Weighted-Average Exercise Price, Awards outstanding, Ending balance Weighted-Average Remaining Contractual Term, Balance Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms RSUs Granted under 2020 Plan Restricted Stock Units R S U [Member] Stock vested during period shares. Share based compensation expense (income). Stock vested Stock Vested During Period Shares Stock-based compensation expense (income) Share Based Compensation Expense Income Share based compensation arrangement by share based payment award fair value assumptions lack of marketability discount. Statistical Measurement Range [Axis] Statistical Measurement Range [Member] Minimum Minimum [Member] Maximum Maximum [Member] Dividend yield Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Expected volatility, minimum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum Expected volatility, maximum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum Risk-free interest rate, minimum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum Risk-free interest rate, maximum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum Lack of marketability discount Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Lack Of Marketability Discount Expected term (years) Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 Weighted average per share fair value of awards issued Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value Stock-based compensation expense Allocated Share Based Compensation Expense Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Income Statement Location Income Statement Location [Axis] Income Statement Location Income Statement Location [Domain] Research and Development Expense Research And Development Expense [Member] Sales and Marketing Expense Selling And Marketing Expense [Member] General and Administrative Expense General And Administrative Expense [Member] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Future Share-Based Compensation Expense Remainder Of Fiscal Year. Future share based compensation expense year one. Future share based compensation expense year two. Future share based compensation expense year three. Future share based compensation expense year four. 2021 (excluding the six months ended June 30, 2021) Future Share Based Compensation Expenses Remainder Of Fiscal Year 2022 Future Share Based Compensation Expense Year One 2023 Future Share Based Compensation Expense Year Two 2024 Future Share Based Compensation Expense Year Three 2025 Future Share Based Compensation Expense Year Four ESPP permits eligible employees to purchase shares of common stock at discount Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Purchase Date Total number of shares reserved for issuance Common Stock Capital Shares Reserved For Future Issuance Shares issued under the ESPP Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period Class Of Warrant Or Right [Table] Class Of Warrant Or Right [Table] Class Of Warrant Or Right [Line Items] Class Of Warrant Or Right [Line Items] Fair value of the Warrants Liabilities Fair Value Disclosure Unamortized debt discount Debt Instrument Unamortized Discount Numerator Net Income Loss [Abstract] Net income (loss) Net income (loss) available to common shareholders Denominator Net income (loss) per common share - basic Net income (loss) per common share - diluted Securities outstanding included in computation of utilizing treasury stock method. Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Antidilutive Securities Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis] Antidilutive Securities, Name Antidilutive Securities Name [Domain] Stock options, SARs, and RSUs. Stock Options, SARs, and RSUs to Purchase Common Stock Stock Option And Stock Stock Appreciation And Restricted Stock Units [Member] Warrants Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Total Securities Outstanding Included In Computation Of Utilizing Treasury Stock Method Employee stock option stock appreciation rights and restricted stock units. Stock Options, SARs, and RSUs to Purchase Common Stock Employee Stock Option Stock Appreciation Rights And Restricted Stock Units [Member] Convertible Preferred Stock Convertible Preferred Stock [Member] Total Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount Schedule Of Related Party Transactions By Related Party [Table] Schedule Of Related Party Transactions By Related Party [Table] Related Party Transaction Related Party Transaction [Axis] Related Party Transaction Related Party Transaction [Domain] Management services agreement. Management Services Agreement Management Services Agreement [Member] Balance Sheet Location Balance Sheet Location [Axis] Balance Sheet Location Balance Sheet Location [Domain] Current liabilities. Current Liabilities Current Liabilities [Member] Prepaid Expenses and Other Assets Prepaid Expenses And Other Current Assets [Member] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Management fee expense and other expenses to related party Related Party Transaction Expenses From Transactions With Related Party Amounts due to related parties - current Due To Related Parties Current Amounts due from related parties Due From Related Parties Noncurrent Debt instrument repayment premium percentage. Subsequent Event [Table] Subsequent Event [Table] Subsequent Event Type Subsequent Event Type [Axis] Subsequent Event Type Subsequent Event Type [Domain] Subsequent Events Subsequent Event [Member] Senior secured term loan. Senior Secured Term Loan Senior Secured Term Loan [Member] Senior secured delayed draw term loan. Senior Secured Delayed Draw Term Loan Senior Secured Delayed Draw Term Loan [Member] New credit facility New Credit Facility New Credit Facility [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Number of shares sold Sale Of Stock Number Of Shares Issued In Transaction Debt instrument repayment premium percentage Debt Instrument Repayment Premium Percentage